Understanding why they happen takes away a lot of the worry, and knowing what genuinely helps means you don't have to just wait them out, and it means these symptoms don't have to derail your Mounjaro weight loss results
In recent years glucagon-like peptide-1 receptor agonists (GLP-1RAs) have been shown in clinical studies to be neuroprotective, to have metabolic benefits and have emerged as effective treatments for both type 2 diabetes and obesity (Astrup, 2024
Side Effects Comparison# Retatrutide Side Effects# Phase 2 data (n=338 obesity trial): Nausea : ~25% at higher doses (8-12 mg) Diarrhea : ~20% Vomiting : ~15% Constipation : Common Decreased appetite : Common (pharmacological effect) Heart rate : Small increase (2-4 bpm), potentially related to glucagon component Injection site reactions : Mild, transient Discontinuation rate : 6-10% due to adverse events The glucagon receptor component introduces theoretical concerns for hyperglycemia (counterbalanced by GLP-1/GIP in practice), cardiovascular effects (chronotropic glucagon action), and hepatic effects, none of which produced safety signals in Phase 2 but require larger-scale monitoring
You can find additional information about the risks of FDA-approved medications that contain semaglutide here
This ensures that the minerals and amino acids needed for pigment and protein construction are delivered efficiently